| Market Cap | ₹67,562Cr |
| ROE | 9.77% |
| P/E Ratio(TTM) | 19.75 |
| EPS(TTM) | 58.38 |
| P/B Ratio | 1.93 |
| Dividend Yield | 0.00% |
| Industry P/E | 33.42 |
| Book Value | 598.04 |
| Debt to Equity | 0.22 |
| Face Value | 1 |
| Parent Organisation | Aurobindo Pharma Limited |
| Managing Director | Mr. K. Nityananda Reddy |
| NSE Symbol | AUROPHARMA |
| COMPANY | 52 WEEK | MARKET PRICE | P/E Ratio | |
|---|---|---|---|---|
| Sun Pharmaceutical Industries | NA (0.00%) | 38.84 | ||
| Cipla | NA (0.00%) | 22.50 | ||
| Dr Reddy's Laboratories | NA (0.00%) | 17.43 | ||
| Zydus Lifesciences | NA (0.00%) | 18.95 |